Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 21 Issue 1

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 21, Issue 1 In this issue Editorial Review Article Article Also new AOP   Editorial 20 years–A retrospective of prostate cancer and prostatic diseases Stephen J Freedland Prostate Cancer and Prostatic Diseases 2017 21 :1 - 3; December 19, 2017; 10.1038/s41391-017-0025-6   Abstract | Full Text Review Article The use of PET/CT in prostate cancer Roger Li, Gregory C. Ravizzini, Michael A. Gorin, Tobias Maurer, Matthias Eiber et al. Prostate Cancer and Prostatic Diseases 2017 21 :4 - 21; December 11, 2017; 10.1038/s41391-017-0007-8   Abstract | Full Text The molecular biology of prostate cancer: current understanding and clinical implications Jason Gandhi, Adil Afridi, Sohrab Vatsia, Gargi Joshi, Gunjan Joshi et al. Prostate Cancer and Prostatic Diseases 2017 21 :22 - 36; December 27, 2017; 10.1038/s41391-017-0023-8   Abstract | Full Text Current approaches to incorporation of radium-223 in clinical practice Chris Parker, Axel Heidenreich, Sten Nilsson & Neal Shore Prostate Cancer and Prostatic Diseases 2018 21 :37 - 47; January 03, 2018; 10.1038/s41391-017-0020-y   Abstract | Full Text Germline BRCA mutation in male carriers-ripe for precision oncology? Ricardo Romão Nazário Leão, Aryeh Joshua Price & Robert James Hamilton Prostate Cancer and Prostatic Diseases 2017 21 :48 - 56; December 14, 2017; 10.1038/s41391-017-0018-5   Abstract | Full Text Article Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer Tobias Nordström, Olof Akre, Markus Aly, Henrik Grönberg & Martin Eklund Prostate Cancer and Prostatic Diseases 2017 21 :57 - 63; December 19, 2017; 10.1038/s41391-017-0024-7   Abstract | Full Text Preoperative prostate health index predicts poor pathologic outcomes of radical prostatectomy in patients with biopsy-detected low-risk patients prostate cancer: results from a Chinese prospective cohort Bo Tang, Cheng-Tao Han, Xiao-Lin Lu, Fang-Ning Wan, Cui-Zhu Zhang et al. Prostate Cancer and Prostatic Diseases 2017 21 :64 - 70; December 06, 2017; 10.1038/s41391-017-0002-0   Abstract | Full Text Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged=50 years: a population-based study Raisa S. Pompe, Ariane Smith, Marco Bandini, Michele Marchioni, Tristan Martel et al. Prostate Cancer and Prostatic Diseases 2018 21 :71 - 77; January 16, 2018; 10.1038/s41391-017-0006-9   Abstract | Full Text Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting Jay White, B. Vittal Shenoy, Ronald F. Tutrone, Lawrence I. Karsh, Daniel R. Saltzstein et al. Prostate Cancer and Prostatic Diseases 2017 21 :78 - 84; November 20, 2017; 10.1038/s41391-017-0008-7   Abstract | Full Text Indication to pelvic lymph nodes dissection for prostate cancer: the role of multiparametric magnetic resonance imaging when the risk of lymph nodes invasion according to Briganti updated nomogram is <5% Francesco Porpiglia, Matteo Manfredi, Fabrizio Mele, Riccardo Bertolo, Enrico Bollito et al. Prostate Cancer and Prostatic Diseases 2018 21 :85 - 91; February 22, 2018; 10.1038/s41391-017-0026-5   Abstract | Full Text Platinum sensitivity in metastatic prostate cancer: does histology matter? Michael S. Humeniuk, Rajan T. Gupta, Patrick Healy, Megan McNamara, Sundhar Ramalingam et al. Prostate Cancer and Prostatic Diseases 2017 21 :92 - 99; December 11, 2017; 10.1038/s41391-017-0017-6   Abstract | Full Text Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomy Mehmet Özsoy, Marco Moschini, Harun Fajkovic, Francesco Soria, Christian Seitz et al. Prostate Cancer and Prostatic Diseases 2017 21 :100 - 105; December 11, 2017; 10.1038/s41391-017-0015-8   Abstract | Full Text Baseline prostate atrophy is associated with lower tumor volume in men with prostate cancer on repeat biopsy Daniel M. Moreira, Gerald L. Andriole, Ramiro Castro-Santamaria & Stephen J. Freedland Prostate Cancer and Prostatic Diseases 2017 21 :106 - 112; December 04, 2017; 10.1038/s41391-017-0012-y   Abstract | Full Text Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model Ying-Chun Shen, Ali Ghasemzadeh, Christina M. Kochel, Thomas R. Nirschl, Brian J. Francica et al. Prostate Cancer and Prostatic Diseases 2017 21 :113 - 125; December 04, 2017; 10.1038/s41391-017-0013-x   Abstract | Full Text Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer Benjamin Benzon, Stephanie A. Glavaris, Brian W. Simons, Robert M. Hughes, Kamyar Ghabili et al. Prostate Cancer and Prostatic Diseases 2018 21 :126 - 136; March 20, 2018; 10.1038/s41391-018-0035-z   Abstract | Full Text Overexpression of a (1,6) fucosyltransferase in the development of castration-resistant prostate cancer cells Naseruddin Höti, Shuang Yang, Yingwei Hu, Punit Shah, Michael C. Haffner et al. Prostate Cancer and Prostatic Diseases 2018 21 :137 - 146; January 16, 2018; 10.1038/s41391-017-0016-7   Abstract | Full Text Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk Yuanjun Ma & Nele Brusselaers Prostate Cancer and Prostatic Diseases 2017 21 :147 - 152; December 19, 2017; 10.1038/s41391-017-0021-x   Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.